America's Benefit Specialist May 2023

CPC QUIZ

7. The No Surprises Act prevented _____ surprise bills in its first nine months of existence. A. 700,000

1. After the end of the public health emergency, employer plans will no longer be required to cover the cost of COVID-19 tests and testing-related services without _____.

B. 1.3 million C. 9 million D. 13 million

A. cost-sharing B. self-funded

C. surprise billing D. COBRA election

8. _____ of hospitals remain non-compliant with the fed eral requirements to publicly post prices for services and drugs. A. Fifty percent B. Seventy percent

2. Several employee benefit plan-related deadlines were suspended for up to _____ as long as the national emer gency was in place.

C. Seventy-five percent D. Eighty-five percent

A. three months B. nine months

C. one year D. two years

9. Congress recently prohibited “_____” in contracts between a plan sponsor and the owner of a provider network with the express purpose of ensuring that electronic claims data and negotiated in-network ser vice pricing is available to self-funded plans and their members. A. gag clauses

3. Once the _____ period following the termination of the national emergency ends, suspended deadline time frames will begin to run again at pre-pandemic rates.

A. 30-day B. 60-day C. 90-day D. 120-day

B. force majeure C. confidentiality D. severability

4. Effective July 11, the _____ deadline for plan adminis trators to provide COBRA-election notices to qualified beneficiaries will resume. A. seven-day

10. A cornerstone of the No Surprises Act is the _____ busi ness period during which there would be good-faith negotiations between plans and healthcare providers.

A. 30-day B. 60-day C. 90-day D. 120-day

B. 14-day C. 21-day D. 30-day

5. The guidance that allowed HSA-qualified _____ plans to offer telehealth coverage on a first-dollar basis with out affecting HSA eligibility is NOT impacted by the end of the public health/national emergency.

11. _____ are medicines that are very close in structure and function to a biologic medicine. A. Generics B. Biosimilars C. Original drugs D. Compounds 12. Biosimilars typically launch at list prices that have been on average _____ lower than the originator product. A. eight percent to 33%

A. self-Funded B. group health C. high-deductible D. individual

6. The average premium for an employer-based family healthcare plan reached _____ in 2021.

A. $12,947 B. $18,305 C. $19,205 D. $22,221

B. 13% to 49% C. 15% to 40% D. 18% to 27%

40 ABS | benefitspecialistmagazine.com